Pearl River Capital, LLC Emergent Bio Solutions Inc. Transaction History

Pearl River Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$33.11 - $55.01 $199,918 - $332,150	-6,038 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$50.07 - $66.05 $144,852 - $191,082	-2,893 Reduced 32.39%	6,038 $302,000
Q2 2021 Aug 13, 2021	BUY	$56.61 - $80.46 $284,125 - $403,828	5,019 Added 128.3%	8,931 $563,000
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $190,309 - $276,294	-2,207 Reduced 36.07%	3,912 $363,000
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $99,279 - $139,783	1,254 Added 25.78%	6,119 $548,000

Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $35,630 - $58,698	-435 Reduced 8.21%	4,865 $503,000
Q2 2020 Aug 10, 2020	BUY	$54.33 - $89.52 $226,175 - $372,671	4,163 Added 366.14%	5,300 $419,000
Q1 2020 May 06, 2020	BUY	$49.34 - $68.76 $56,099 - $78,180	1,137 New	1,137 $66,000
Q2 2019 Aug 12, 2019	SELL	$39.92 - $53.86 $26,267 - $35,439	-658 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$48.23 - $66.16 $31,735 - $43,533	658 New	658 $34,000

136

35.6M

78.7K

75.1K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $376M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.